openPR Logo
Press release

Postoperative Pain Therapeutics Market Trends Research Report Analysis Revealing Key Drivers & Growth Trends through 2026

10-05-2020 01:25 PM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research (TMR) has published a new report, titled, ‘Postoperative Pain Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′. According to the postoperative pain therapeutics market report, the global postoperative pain therapeutics market was valued at US$ 11,459.3 Mn in 2018, and is projected to expand at a CAGR of nearly 4.5% from 2019 to 2027. High incidence and severity of postoperative pain, introduction of promising drugs, increase in the number of surgical procedures, and high rate of adoption of pain management in developed as well as pharmerging countries are spurring the growth of the global postoperative pain therapeutics market.

North America and Europe are projected to be prominent regions in the global postoperative pain therapeutics market during the forecast period. The postoperative pain therapeutics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. The growth of the postoperative pain therapeutics market in the region is attributed to the high rate of adoption of pain management, rise in disposable income, and increase in the number of surgical procedures. The postoperative pain therapeutics market in Latin America is likely to grow at a moderate pace during the forecast period.

Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=67271

postoperative pain therapeutics segmentation
Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=67271

High Incidence and Severity of Postoperative Pain, Introduction of Promising Drugs, and High Adoption Rate of Pain Management in Developed as well as Pharmerging Countries to Drive the Postoperative Pain Therapeutics Market

The global postoperative pain therapeutics market is projected to be driven by the following factors. Surgical procedures are associated with chronic postoperative pain that persists for a long time, usually for three to six months. Phantom pain is one the common postoperative conditions that occurs after limb amputation, thoracotomy, breast surgery, cesarean section, or inguinal hernia repair.
A number of studies conducted in countries with highly-developed healthcare systems demonstrated that, postoperative pain is not managed well in nearly one-third to one-half of the patients. Increase in the number of surgical procedures and severity of postoperative pain are anticipated to drive the global postoperative pain therapeutics market during the forecast period. The introduction of various new drugs is also expected to propel the global postoperative pain therapeutics market. New drugs are being developed with wide safety margins and favorable profiles.
Advancements in non-opioid alternatives and adjuncts have gained importance for controlling postoperative pain. For instance, intravenous (IV) acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), magnesium, ketamine, dexmedetomidine, and liposomal bupivacaine are some of the drugs that have gained traction in the postoperative pain therapeutics market.
Innovative medicines, increase in demand, better access, and improved treatment for pain have led to the dominance of postoperative pain therapeutics in pharmerging and developed markets.
Buy Now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=67271<ype=S

Opioids Projected to be a Highly Lucrative Drug Class in the Postoperative Pain Therapeutics Market

Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. Opioids can be classified into three major classes: strong agonists (fentanyl, oxymorphone, and morphine), mild-to-moderate agonists (codeine and hydroxycodone), and opioids with mixed receptor reactions (buprenophrine and pentazocine).
The opioids segment dominated the postoperative pain therapeutics market in 2018, and the trend is likely to continue during the forecast period. Growth of the segment can be attributed to the usage of opioids as the primary line of treatment for postoperative pain.
However, an increase in the incidences of opioid drug abuse due to addiction, and production shortage of opioids, as reported by Pfizer, are projected to hamper the growth of the postoperative pain therapeutics market in the next few years.
Oral Route of Administration Leads in the Postoperative Pain Therapeutics Market

Oral administration is a route of administration, wherein, medications are taken through the mouth. Medications taken through this route are intended to have a systemic effect and reach different body parts through the bloodstream.
The postoperative pain therapeutics market report offers detailed segmentation of the global postoperative pain therapeutics market in terms of route of administration. The oral segment is poised to account for a substantial share of the postoperative pain therapeutics market from 2019 to 2027. High share of the segment is attributed to easy intake, and preference of patients of taking medication orally.
The oral segment dominated the postoperative pain therapeutics market in 2018, and this trend is projected to continue during the forecast period. Growth of the segment can be attributed to high preference for the oral route of administration, owing to its non-invasiveness, ease of use, and self-administration.
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Hospital Pharmacies Segment Prominent in the Postoperative Pain Therapeutics Market

In terms of distribution channel, the hospital pharmacies segment accounted for a leading share of the global postoperative pain therapeutics market in 2018. This segment is likely to gain market share in the postoperative pain therapeutics market during the forecast period.
The segment is expected to expand at a high CAGR from 2019 to 2027. Hospital pharmacies can be defined as healthcare facilities inside hospital premises that primarily provide medications to hospital patients. These facilities manage the procurement, storage, packaging, preservation, compounding, sterilization, and distribution of medicines in hospitals.
Growth of the segment can be attributed to the rise in the number of surgeries being performed. Additionally, increase in the number of accidents leading to complicated surgeries result in postoperative pain.
This drives the demand for postoperative analgesics. Moreover, product availability in hospital pharmacies contributes to the growth of the segment.
Asia Pacific Presents Significant Opportunities in the Postoperative Pain Therapeutics Market

North America and Europe accounted for large shares in the global postoperative pain therapeutics market in 2018, and are projected to gain more market share in the global postoperative pain therapeutics market by the end of 2027. The postoperative pain therapeutics markets in these two regions are anticipated to expand significantly in the next few years, due to the increase in inpatient and outpatient surgeries and well-established healthcare infrastructure. Rise in obesity and lack of exercise have contributed to the high prevalence of chronic disorders, which leads to high number of surgeries.
An article published by NCBI stated that, acute pain control leads to approximately 70 million surgical procedures in the U.S. each year. The postoperative pain therapeutics market in Asia Pacific is expanding rapidly due to improving healthcare infrastructure, and rise in private and public investment in life science research in countries such as China and India. Robust economic development, high chronic disease burden, and developing healthcare sector are anticipated to boost the postoperative pain therapeutics market in Asia Pacific.
China and Japan are expected to be highly attractive markets for postoperative pain therapeutics in the next few years, due to the increase in the incidences of chronic diseases and rise in the geriatric population. Launch of new products and introduction of abuse-deterrent opioid analgesics in Asia Pacific are likely to drive the opioids segment in the region from 2019 to 2027.
The phenomenon of population aging in Japan, China, and India has led to an increase in the number of people with chronic pain, cancer pain, and other diseases. This is expected to drive the NSAIDS and opioids segments in the region during the forecast period.
Key Trend of Acquisition and Collaboration among Leading Players to Increase their Geographic Presence in the Postoperative Pain Therapeutics Market

The postoperative pain therapeutics market report also provides the profiles of leading players operating in global postoperative pain therapeutics market, such as Mallinckrodt Pharmaceuticals, Pacira BioSciences, Inc., Trevena, Inc., Heron Therapeutics, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Camarus, Eli Lilly & Company, and Bayer AG.
These companies strive to increase their geographic presence through strategic acquisitions and collaborations with leading players in respective domains and regions.
The global postoperative pain therapeutics market has been segmented as below:

Global Postoperative Pain Therapeutics Market by Drug Class

Opioids
NSAIDS
Local Anesthetics
Tricyclic Antidepressants
Antiepileptic Drugs
Others
Global Postoperative Pain Therapeutics Market by Route of Administration

Oral
Intramuscular
Intravenous
Others
Global Postoperative Pain Therapeutics Market by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Postoperative Pain Therapeutics Market by Region

North AmericaU.S.
Canada
EuropeU.K.
Germany
France
Italy
Spain
Rest of Europe
Asia PacificChina
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin AmericaBrazil
Mexico
Rest of Latin America
Middle East & AfricaGCC
South Africa
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. http://www.prnewswire.com/news-releases/despite-several-factors-supporting-osteoporosis-drugs-market-patent-expiration-of-blockbuster-drugs-to-hamper-markets-progress-tmr-301019711.html

2. https://www.biospace.com/article/rising-healthcare-concerns-spark-off-growth-in-global-telepharmacy-market/

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postoperative Pain Therapeutics Market Trends Research Report Analysis Revealing Key Drivers & Growth Trends through 2026 here

News-ID: 2149364 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and